• DOI:10.1007/BF03256896
Corpus ID: 15893493

Stem Cell-Based Toxicity Screening

@article{Greenhough2012StemCT,
  title={Stem Cell-Based Toxicity Screening},
  author={S. Greenhough and D. Hay},
  journal={Pharmaceutical Medicine},
  year={2012},
  volume={26},
  pages={85-89}
}

S. Greenhough, D. Hay

Published 2012

Biology

Pharmaceutical Medicine

Preclinical cell-based toxicity screening is an essential stage in the drug development process. Current technology is based on immortalized cell lines, rodent cells and primary human hepatocytes, all of which suffer from shortcomings. Cell lines and rodent cells have limited relevance to human physiology, while primary human cells remain a scarce and variable resource. These systems are inadequate, as evidenced by the high levels of compound attrition in the clinical trial and postmarketing… CONTINUE READING

View on Springer

Save to Library

Create Alert

Cite

Launch Research Feed